Theresa Heggie, Senior VP of Global Commercial Operations at Shire Human Genetic Therapies, presented at last year's World Orphan Drug Congress USA on the topic âThe development and commercialization of drugs for patients with orphan diseases.'
Do you want to learn more about:
- Encouraging responsibility and urgency to meet patients' needs
- Partnering long-term with patient organizations, healthcare professionals and payers
- Engaging employees through Shire's BRAVE culture
If so, you need to check out the video below: